Down -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon (ANNX) [Yahoo! Finance]
Annexon, Inc. (NASDAQ: ANNX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Are Medical Stocks Lagging Annexon (ANNX) This Year? [Yahoo! Finance]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Annexon, Inc. (NASDAQ: ANNX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.